Ameritas Investment Partners’s Asensus Surgical, Inc. ASXC Stock Holding History

Ameritas Investment Partners’s Portfolio ASXC Stock Details ASXC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-18,346	Closed	-$11K	–	3283
2022 Q1	$11K	Hold	18,346	–	–	﹤0.01%	2779
2021 Q4	$20K	Hold	18,346	–	–	﹤0.01%	2664
2021 Q3	$34K	Hold	18,346	–	–	﹤0.01%	2400
2021 Q2	$58K	Buy	+18,346	New	+$45.9K	﹤0.01%	2093
2020 Q2	–	Sell	-962	Closed	–	–	3155
2020 Q1	$0	Hold	962	–	–	﹤0.01%	3038
2019 Q4	$1K	Sell	962 -1	-0.1%	-$3	﹤0.01%	3002
2019 Q3	$8K	Hold	963	–	–	﹤0.01%	2826
2019 Q2	$17K	Hold	963	–	–	﹤0.01%	2545
2019 Q1	$30K	Hold	963	–	–	﹤0.01%	2165
2018 Q4	$28K	Hold	963	–	–	﹤0.01%	2150
2018 Q3	$73K	Hold	963	–	–	﹤0.01%	1757
2018 Q2	$55K	Buy	+963	New	+$35.1K	﹤0.01%	1934
2017 Q2	–	Sell	-198	Closed	-$3K	–	3059
2017 Q1	$3K	Buy	+198	New	+$3.43K	﹤0.01%	2905

Other funds holding ASXC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

SHI

SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Ameritas Investment Partners's ASXC Position: Q2 2022 in Review

Ameritas Investment Partners sold out of Asensus Surgical, Inc. (ASXC) in Q2 2022, closing a stake of 18,346 shares — an estimated $11K sold.

Ameritas Investment Partners first reported a position in ASXC in Q1 2017 and held it in 13 quarters. The position peaked at $73K in Q3 2018. 91 funds tracked by Wall St. Rank hold ASXC as of Q2 2022.

Ameritas Investment Partners reported no remaining Asensus Surgical, Inc. position as of Q2 2022 after selling out during the quarter.
Ameritas Investment Partners sold 18,346 Asensus Surgical, Inc. shares in Q2 2022, an estimated $11K.
Ameritas Investment Partners first reported a position in Asensus Surgical, Inc. in Q1 2017 and held it in 13 quarters.
Ameritas Investment Partners's Asensus Surgical, Inc. position peaked at $73K in Q3 2018.
91 funds tracked by Wall St. Rank held Asensus Surgical, Inc. as of Q2 2022.

Based on Ameritas Investment Partners's 13F filing for Q2 2022, filed 12 Aug 2022.